Physician profile
Venu Reddy
NPI 1164429957
$5,549.39
in general payments reported to CMS, 2019-2025
30 companies · $1,751 in 2025
The $1,751 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $154 · 2022: $314 · 2023: $1,542 · 2024: $1,788 · 2025: $1,751.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,081.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,081.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,304.18 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $1,151.35 | 2022-2025 | Fasenra, Tezspire, Airsupra |
| Regeneron Healthcare Solutions, INC. | $519.88 | 2023-2025 | Dupixent |
| Genzyme Corporation | $333.72 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $312.44 | 2023-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Amgen INC. | $277.90 | 2022-2025 | Tezspire, Tavneos |
| Actelion Pharmaceuticals US, INC. | $194.53 | 2023-2025 | Opsumit, Uptravi |
| Electromed, INC. | $193.81 | 2022-2024 | Smartvest |
| Insmed, INC. | $138.31 | 2022-2025 | Arikayce |
| Mylan Specialty L.P. | $132.38 | 2023-2024 | Yupelri |
| Harmony Biosciences LLC | $103.13 | 2023-2025 | Wakix |
| Grifols USA, LLC | $95.27 | 2023-2025 | Prolastin-C Liquid |
| E.R. Squibb & Sons, L.L.C. | $91.94 | 2019 | |
| United Therapeutics Corporation | $82.30 | 2025 | Tyvaso |
| Jazz Pharmaceuticals INC. | $73.59 | 2024-2025 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $72.07 | 2024-2025 | Nuzyra |
| Mallinckrodt Hospital Products INC. | $68.01 | 2025 | Acthar |
| Resmed Corp | $46.01 | 2023 | |
| Viatris Specialty LLC | $44.30 | 2025 | Yupelri |
| Verona Pharma, INC. | $42.53 | 2025 | Ohtuvayre |
| Baxter Healthcare | $42.42 | 2023-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Merck Sharp & Dohme LLC | $41.60 | 2024-2025 | Winrevair, Gardasil 9, Capvaxive |
| Axsome Therapeutics, INC. | $36.30 | 2025 | Sunosi |
| Abbvie INC. | $27.51 | 2023-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $25.19 | 2023 | Glassia |
| Novartis Pharmaceuticals Corporation | $24.60 | 2025 | |
| Alexion Pharmaceuticals, INC. | $23.12 | 2023 | Ultomiris |
| Philips North America LLC | $19.37 | 2023 | |
| Lilly USA, LLC | $16.29 | 2025 | Zepbound |
| Itamar Medical INC | $15.34 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Venu Reddy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.